search
Back to results

China Plant Sterol Trial

Primary Purpose

Hypercholesterolemia, Cardiovascular Diseases

Status
Completed
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
Plant sterol enriched milk tea
Sponsored by
The George Institute
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypercholesterolemia focused on measuring Phytosterols, Cholesterol, China, Randomized controlled trial

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: The key inclusion criteria will be: Age between 18 and 65 years old (inclusive) at baseline Able to provide informed consent Usual diet that includes significant fat consumption at the main meals eaten each week and/or a history of hypercholesterolemia Participant is likely to comply with the study treatment during the study period Exclusion Criteria: Participants will be excluded on the basis of: Known serious gastrointestinal disease or other serious illness. Individuals with stable cardiovascular disease will, however, be eligible Known lactose intolerance or diet that excludes dairy products Known Sitosterolaemia (a very rare genetic condition causing very high blood sitosterol levels) Current hospitalisation Current use of drug with likely significant impact on gastro-intestinal absorption of cholesterol or plant sterol (e.g. ezetimibe, bile acid-binding resins, or orlistat) Participant is currently using or is planning to use non-trial plant sterol/stanol-containing products for the seven week study period Participation in another study within last 3 months Pregnant or planning to become pregnant in next three months

Sites / Locations

  • Peking University Health Science Centre

Outcomes

Primary Outcome Measures

Low density lipoprotein cholesterol levels

Secondary Outcome Measures

Total cholesterol levels;
High density lipoprotein cholesterol levels;
Triglycerides levels;
Liking and adherence

Full Information

First Posted
September 2, 2005
Last Updated
September 2, 2005
Sponsor
The George Institute
Collaborators
Peking University
search

1. Study Identification

Unique Protocol Identification Number
NCT00145717
Brief Title
China Plant Sterol Trial
Official Title
China Plant Sterol Trial - A Randomised Trial to Determine the Effects on Blood Cholesterol Levels of a Milk Tea Product Enriched With Plant Sterol Among 300 Chinese Living in Beijing
Study Type
Interventional

2. Study Status

Record Verification Date
September 2005
Overall Recruitment Status
Completed
Study Start Date
April 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
The George Institute
Collaborators
Peking University

4. Oversight

5. Study Description

Brief Summary
The aim of this study is to see if plant sterols are effective at lowering blood cholesterol levels in Chinese people. The study will be done with Chinese colleagues based at Peking University in Beijing with whom our Institute has a well-established collaboration. The study will be randomised, placebo-controlled and double-blind. The total study period for participants will be an average of seven weeks comprised of a two-week placebo run-in period and a five-week follow-up on randomised treatment. Randomised treatment will comprise either placebo, low- or standard-dose plant sterol. The primary outcome for the study will be blood cholesterol levels.
Detailed Description
RESEARCH PLAN The study is a randomised, double-blind, placebo-controlled trial with three parallel groups, two assigned different doses of active treatment and one assigned placebo. The total study period for participants will be an average of seven weeks comprised of a two-week placebo treatment run-in period prior to randomisation and a five-week follow-up on randomised treatment. An estimated 400 participants will be commenced on run-in with the expectation that 300 (100 in each group) will go on to randomisation. STUDY TREATMENTS Pre-randomisation open run-in phase: All potentially eligible participants will commence a 10-20 days run-in period with the placebo milk tea administered twice daily. This run-in period will help to identify before randomisation, those individuals who are unlikely to tolerate the milk tea product or comply with the study follow up procedures. Post randomisation double-blind treatment phase: Participants that successfully complete the run-in phase will be assigned at random to receive either: Milk tea containing a total of 2.3g of plant sterol each day administered in two divided doses of 1.15g; or Milk tea containing a total of 1.5g of plant sterol each day administered in two divided doses of 0.75g; or Placebo milk tea containing no plant sterol. Blinding of participants and investigators will be assured by providing all groups with their allocated treatment in packaging that is identical except for a unique identifying number corresponding to the randomisation code. Comparisions: 2.3g/d treatment group compared to placebo group 1.5g/d treatment group compared to placebo group active treatment group (2.3g/d and 1.5g/d combined) compared to placebo group 2.3g/d treatment group compared to 1.5g/d treatment group Secondary: To establish the effects of the same intervention on total cholesterol levels.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolemia, Cardiovascular Diseases
Keywords
Phytosterols, Cholesterol, China, Randomized controlled trial

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
300 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Plant sterol enriched milk tea
Primary Outcome Measure Information:
Title
Low density lipoprotein cholesterol levels
Secondary Outcome Measure Information:
Title
Total cholesterol levels;
Title
High density lipoprotein cholesterol levels;
Title
Triglycerides levels;
Title
Liking and adherence

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The key inclusion criteria will be: Age between 18 and 65 years old (inclusive) at baseline Able to provide informed consent Usual diet that includes significant fat consumption at the main meals eaten each week and/or a history of hypercholesterolemia Participant is likely to comply with the study treatment during the study period Exclusion Criteria: Participants will be excluded on the basis of: Known serious gastrointestinal disease or other serious illness. Individuals with stable cardiovascular disease will, however, be eligible Known lactose intolerance or diet that excludes dairy products Known Sitosterolaemia (a very rare genetic condition causing very high blood sitosterol levels) Current hospitalisation Current use of drug with likely significant impact on gastro-intestinal absorption of cholesterol or plant sterol (e.g. ezetimibe, bile acid-binding resins, or orlistat) Participant is currently using or is planning to use non-trial plant sterol/stanol-containing products for the seven week study period Participation in another study within last 3 months Pregnant or planning to become pregnant in next three months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bruce C Neal, MRCP, PhD
Organizational Affiliation
The George Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peking University Health Science Centre
City
Beijing
ZIP/Postal Code
100083
Country
China

12. IPD Sharing Statement

Citations:
PubMed Identifier
17617940
Citation
Li NY, Li K, Qi Z, Demonty I, Gordon M, Francis L, Molhuizen HO, Neal BC. Plant sterol-enriched milk tea decreases blood cholesterol concentrations in Chinese adults: a randomised controlled trial. Br J Nutr. 2007 Nov;98(5):978-83. doi: 10.1017/S0007114507754302. Epub 2007 Jul 9.
Results Reference
derived

Learn more about this trial

China Plant Sterol Trial

We'll reach out to this number within 24 hrs